Publication A phase 1 antigen dose escalation trial to evaluate safety, tolerability and immunogenicity of the leprosy vaccine candidate LepVax (LEP-F1 + GLA-SE) in healthy adults. Duthie M, Frevol A, Day T, et al. Vaccine. 2019;
Publication Protective efficacy of BCG against leprosy in Northern Malawi. Fine PE, Ponnighaus J M, Maine N, et al. Lancet. 1986; 2 (8505) : 499-502. Download PDF
